NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

Leading pharmaceutical companies such as Mylan Pharmaceuticals Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and many others are actively involved in developing innovative ...

the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir tablets and ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2916. The stock has experienced fluctuations tod ...

GlaxoSmithKline was formerly called GlaxoWelcome ... and mainframe and security applications. Aviva plc is a leading international insurer with 33.4 million customers globally.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...